{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T13:12:28Z","timestamp":1778850748030,"version":"3.51.4"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008501","name":"East Carolina University","doi-asserted-by":"publisher","award":["111110-668715-0000"],"award-info":[{"award-number":["111110-668715-0000"]}],"id":[{"id":"10.13039\/100008501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008501","name":"East Carolina University","doi-asserted-by":"publisher","award":["111104"],"award-info":[{"award-number":["111104"]}],"id":[{"id":"10.13039\/100008501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Biological Regulation"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.jbior.2020.100739","type":"journal-article","created":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T16:09:05Z","timestamp":1593187745000},"page":"100739","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Cancer therapy and treatments during COVID-19 era"],"prefix":"10.1016","volume":"77","author":[{"given":"Shaw M.","family":"Akula","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen L.","family":"Abrams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda S.","family":"Steelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1255-6666","authenticated-orcid":false,"given":"Saverio","family":"Candido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Libra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kvin","family":"Lerpiriyapong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9206-8277","authenticated-orcid":false,"given":"Lucio","family":"Cocco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9684-714X","authenticated-orcid":false,"given":"Giulia","family":"Ramazzotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Ratti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6126-0859","authenticated-orcid":false,"given":"Matilde Y.","family":"Follo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5196-7260","authenticated-orcid":false,"given":"Alberto M.","family":"Martelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William L.","family":"Blalock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuela","family":"Piazzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Montalto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melchiorre","family":"Cervello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Notarbartolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorg","family":"Basecke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James A.","family":"McCubrey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbior.2020.100739_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.32969","article-title":"Management of primary skin cancer during a pandemic: multidisciplinary recommendations","author":"Baumann","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.jbior.2020.100739_bib2","doi-asserted-by":"crossref","DOI":"10.1093\/neuonc\/noaa113","article-title":"Neuro-oncology management during the COVID-19 pandemic with a focus on WHO grade III and IV gliomas","author":"Bernhardt","year":"2020","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.jbior.2020.100739_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.athoracsur.2020.05.003","article-title":"Pandemic recovery using a Covid-minimal cancer surgery pathway","author":"Boffa","year":"2020","journal-title":"Ann. Thorac. Surg."},{"key":"10.1016\/j.jbior.2020.100739_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/jso.26057","article-title":"Management of patients with ovarian cancer in the COVID-19 era","author":"Bogani","year":"2020","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.jbior.2020.100739_bib5","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2016638","article-title":"A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19","author":"Boulware","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.jbior.2020.100739_bib6","first-page":"578","article-title":"Early tocilizumab treatment could improve survival among COVID-19 patients","volume":"38","author":"Campins","year":"2020","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jbior.2020.100739_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2020.05.019","article-title":"Ruxolitinib in treatment of severe coronavirus disease 2019 (COVID-19): a multicenter, single blind, randomized controlled trial","author":"Cao","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.jbior.2020.100739_bib8","first-page":"1","article-title":"Identification of potential inhibitors of SARS-COV-2 endoribonuclease (EndoU) from FDA approved drugs: a drug repurposing approach to find therapeutics for COID19","volume":"28","author":"Chandra","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.jbior.2020.100739_bib9","article-title":"When cancer encounters COVID-19 in China: what have we suffered, experienced and learned","author":"Chen","year":"2020","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.jbior.2020.100739_bib10","doi-asserted-by":"crossref","first-page":"104901","DOI":"10.1016\/j.phrs.2020.104901","article-title":"Anti-malarial drug, artemisinin and its derivatives for the treatment of respiratory diseases","volume":"158","author":"Cheong","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.jbior.2020.100739_bib11","first-page":"472","volume":"21","author":"Cuadrado-Lavin","year":"2020","journal-title":"Trials [Electronic Resource]"},{"issue":"12","key":"10.1016\/j.jbior.2020.100739_bib12","doi-asserted-by":"crossref","first-page":"6771","DOI":"10.1073\/pnas.1922083117","article-title":"Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection","volume":"117","author":"de Wit","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbior.2020.100739_bib13","article-title":"An inflammatory cytokine signature helps predict COVID-19 severity and death","author":"Del Valle","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.jbior.2020.100739_bib14","article-title":"Weathering the storm: managing older adults with breast cancer amid COVID-19 and beyond","author":"Freedman","year":"2020","journal-title":"J. Nat. Canc.Inst."},{"key":"10.1016\/j.jbior.2020.100739_bib15","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2012410","article-title":"Observational study of hydroxychloroquine in hospitalized patients with Covid-19. 2020","author":"Geleris","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.jbior.2020.100739_bib16","doi-asserted-by":"crossref","first-page":"E129","DOI":"10.3390\/biomedicines8050129","volume":"8","author":"Glinsky","year":"2020","journal-title":"Biomedicines"},{"issue":"6","key":"10.1016\/j.jbior.2020.100739_bib17","doi-asserted-by":"crossref","first-page":"E1378","DOI":"10.3390\/cancers12061378","article-title":"PARP inhibitors in the treatment of early breast cancer: the step beyond?","volume":"12","author":"Gon\u00e7alves","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.jbior.2020.100739_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/hed.26272","article-title":"Care in the time of coronavirus: ethical considerations in head and neck oncology","author":"Gordin","year":"2020","journal-title":"Head Neck"},{"key":"10.1016\/j.jbior.2020.100739_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2286-9","article-title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing","author":"Gordon","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.jbior.2020.100739_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.21656","article-title":"Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics","author":"Gurwitz","year":"2020","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.jbior.2020.100739_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.21689","article-title":"Repurposing current therapeutics for treating COVID-19: a vital role of prescription records data mining","author":"Gurwitz","year":"2020","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.jbior.2020.100739_bib22","article-title":"Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID-19 pandemic: the Princess Margaret experience and proposal","author":"Huang","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.jbior.2020.100739_bib23","doi-asserted-by":"crossref","first-page":"102982","DOI":"10.1016\/j.critrevonc.2020.102982","article-title":"Considerations for interactions of drugs used for the treatment of COVID-19 with anti-cancer treatments","volume":"151","author":"Jafari","year":"2020","journal-title":"[Review] Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.jbior.2020.100739_bib24","article-title":"Surgical resection for liver cancer during the COVID-19 outbreak","author":"Jeddou","year":"2020","journal-title":"Updates Surg."},{"key":"10.1016\/j.jbior.2020.100739_bib25","doi-asserted-by":"crossref","first-page":"109878","DOI":"10.1016\/j.mehy.2020.109878","article-title":"Selenium supplementation in the prevention of coronavirus infections (COVID-19)","volume":"143","author":"Kieliszek","year":"2020","journal-title":"Med. Hypotheses"},{"issue":"4","key":"10.1016\/j.jbior.2020.100739_bib26","doi-asserted-by":"crossref","first-page":"R108","DOI":"10.1186\/cc6995","article-title":"Inflammatory and transcriptional roles of poly (ADP-ribose) polymerase in ventilator-induced lung injury","volume":"12","author":"Kim","year":"2008","journal-title":"Crit. Care"},{"key":"10.1016\/j.jbior.2020.100739_bib27","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1001\/jama.1918.02600440062019","article-title":"The treatment of \u201cSpanish influenza\u201d","volume":"71","author":"Klein","year":"1918","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.jbior.2020.100739_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(20)31187-9","article-title":"Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study","author":"Kuderer","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jbior.2020.100739_bib29","first-page":"109848","article-title":"Potential role of zinc supplementation in prophylaxis and treatment of COVID-19 [published online ahead of print, 2020 May 25]","author":"Kumar","year":"2000","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.jbior.2020.100739_bib30","article-title":"COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study","author":"Lee","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jbior.2020.100739_bib31","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.ccell.2017.04.012","article-title":"Inhibition of B cell receptor signaling by Ibrutinib in primary CNS lymphoma","volume":"31","author":"Lionakis","year":"2017","journal-title":"Canc. Cell"},{"issue":"2","key":"10.1016\/j.jbior.2020.100739_bib32","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/jcmm.12967","article-title":"HYDAMTIQ, a selective PARP-1 inhibitor, improves bleomycin-induced lung fibrosis by dampening the TGF-beta\/SMAD signalling pathway","volume":"21","author":"Lucarini","year":"2017","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.jbior.2020.100739_bib33","article-title":"Focus on receptors for coronaviruses with special reference to angiotensin-converting enzyme 2 as a potential drug target - a perspective","author":"Magrone","year":"2020","journal-title":"Endocr. Metab. Immune Disord. - Drug Targets"},{"key":"10.1016\/j.jbior.2020.100739_bib34","article-title":"Indomethacin and resveratrol as potential treatment adjuncts for SARS-CoV-2\/COVID-19 [published online ahead of print, 2020 May 15]","author":"Marinella","year":"2020","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.jbior.2020.100739_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.chest.2020.04.020","article-title":"Management of lung nodules and lung cancer screening during the COVID-19 Pandemic: CHEST expert panel report","author":"Mazzone","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.jbior.2020.100739_bib36","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.18632\/aging.101250","article-title":"Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs","volume":"9","author":"McCubrey","year":"2017","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.jbior.2020.100739_bib37","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jbior.2017.09.012","article-title":"Effects of berberine, curcumin, resveratrol alone and in combination with chemotherapeutic drugs and signal transduction inhibitors on cancer cells-Power of nutraceuticals","volume":"67","author":"McCubrey","year":"2018","journal-title":"Adv. Biol. Regul."},{"key":"10.1016\/j.jbior.2020.100739_bib38","doi-asserted-by":"crossref","DOI":"10.2217\/pgs-2020-0059","article-title":"Targeted therapies for cancer during the COVID-19 pandemic: a threat or a blessing?","author":"Moujaess","year":"2020","journal-title":"Pharmacogenomics"},{"issue":"1","key":"10.1016\/j.jbior.2020.100739_bib39","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12943-018-0779-z","article-title":"Role of Bruton's tyrosine kinase in B cells and malignancies","volume":"17","author":"Pal Singh","year":"2019","journal-title":"Mol. Canc."},{"issue":"12","key":"10.1016\/j.jbior.2020.100739_bib40","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.3390\/cancers11121834","article-title":"Overcoming Ibrutinib resistance in chronic lymphocytic leukemia","volume":"11","author":"Pu\u0142a","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.jbior.2020.100739_bib41","doi-asserted-by":"crossref","first-page":"104904","DOI":"10.1016\/j.phrs.2020.104904","article-title":"The possible mechanisms of action of 4-aminoquinolines (chloroquine\/hydroxychloroquine) against Sars-Cov-2 infection (COVID-19): a role for iron homeostasis?","volume":"158","author":"Quiros Roldan","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jbior.2020.100739_bib42","doi-asserted-by":"crossref","first-page":"117839","DOI":"10.1016\/j.lfs.2020.117839","article-title":"Coronaviruses pathogenesis, comorbidities and multi-organ damage - a review","volume":"255","author":"Renu","year":"2020","journal-title":"[Review] Life Sci."},{"key":"10.1016\/j.jbior.2020.100739_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2020.05.001","article-title":"The liver in times of COVID-19: what hepatologists should know","author":"Ridruejo","year":"2020","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.jbior.2020.100739_bib68","doi-asserted-by":"crossref","DOI":"10.1007\/s12094-020-02381-z","article-title":"Covid-19 transmission, outcome and associated risk factors in cancer patients at the first month of the pandemic in a Spanish hospital in Madrid","author":"Rogado","year":"2020","journal-title":"Clinical & Translational Oncology: Official Publication of the Federation of Spanish Oncology Societes & of the National Cancer Institute of Mexico"},{"key":"10.1016\/j.jbior.2020.100739_bib69","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.lungcan.2020.05.034","article-title":"Covid-19 and lung cancer: A greater fatality rate?","volume":"146","author":"Rogado","year":"2020","journal-title":"Lung Cancer"},{"issue":"48","key":"10.1016\/j.jbior.2020.100739_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abd0110","article-title":"Inhibition of Bruton tyrosine kinase in patients with severe COVID-19","volume":"5","author":"Roschewski","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.jbior.2020.100739_bib45","doi-asserted-by":"crossref","first-page":"173091","DOI":"10.1016\/j.ejphar.2020.173091","article-title":"Pharmacological inhibition of poly (ADP-ribose) polymerase by olaparib, prevents acute lung injury associated cognitive deficits potentially through suppression of inflammatory response","volume":"877","author":"Sahu","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jbior.2020.100739_bib46","first-page":"1","article-title":"Elective procedures for prostate cancer in the time of Covid-19: a multidisciplinary team experience","author":"Sciarra","year":"2020","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.jbior.2020.100739_bib47","doi-asserted-by":"crossref","DOI":"10.1177\/0846537120928864","article-title":"COVID-19: safe guidelines for breast imaging during the pandemic","author":"Seely","year":"2020","journal-title":"Can. Assoc. Radiol. J."},{"issue":"1","key":"10.1016\/j.jbior.2020.100739_bib48","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/s41467-019-13940-6","article-title":"Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV","volume":"11","author":"Sheahan","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jbior.2020.100739_bib49","doi-asserted-by":"crossref","DOI":"10.1200\/OP.20.00286","article-title":"Management of lung cancer during the COVID-19 pandemic","author":"Singh","year":"2020","journal-title":"JCO Oncol. Pract."},{"key":"10.1016\/j.jbior.2020.100739_bib50","doi-asserted-by":"crossref","DOI":"10.1007\/s11605-020-04645-z","article-title":"Caring for patients with rectal cancer during the COVID-19 pandemic","author":"Skowron","year":"2020","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.jbior.2020.100739_bib51","first-page":"1","article-title":"Cytokine storm in COVID-19: pathogenesis and overview of anti-inflammatory agents used in treatment","author":"Soy","year":"2020","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.jbior.2020.100739_bib52","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.radonc.2020.04.010","article-title":"Recommendations for the use of radiation therapy in managing patients with gastrointestinal malignancies in the era of COVID-19","volume":"148","author":"Tchelebi","year":"2020","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.jbior.2020.100739_bib53","doi-asserted-by":"crossref","DOI":"10.1038\/s41375-020-0876-z","article-title":"Management of patients with multiple myeloma in the era of COVID-19 pandemic: a consensus paper from the European Myeloma Network (EMN)","author":"Terpos","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.jbior.2020.100739_bib54","article-title":"Covid-19 transmission, outcome and associated risk factors in cancer patients at the first month of the pandemic in a Spanish hospital in Madrid","author":"Triki","year":"2020","journal-title":"Clin. Transl. Oncol.: Official Publication of the Federation of Spanish Oncology Societes & of the National Cancer Institute of Mexico"},{"key":"10.1016\/j.jbior.2020.100739_bib55","doi-asserted-by":"crossref","first-page":"106028","DOI":"10.1016\/j.ijantimicag.2020.106028","article-title":"A review on possible modes of action of chloroquine\/hydroxychloroquine: repurposing against SAR-CoV-2 (COVID-19) pandemic","author":"Tripathy","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.jbior.2020.100739_bib56","doi-asserted-by":"crossref","DOI":"10.1158\/2159-8290.CD-20-0559","article-title":"The landscape of human cancer proteins targeted by SARS-CoV-2","author":"Tutuncuoglu","year":"2020","journal-title":"Canc. Discov."},{"key":"10.1016\/j.jbior.2020.100739_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2020.05.002","article-title":"Immunology of COVID-19: current state of the science","author":"Vabret","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.jbior.2020.100739_bib58","doi-asserted-by":"crossref","DOI":"10.1634\/theoncologist.2020-0316","article-title":"Personalized risk-benefit ratio adaptation of breast cancer care at the epicenter of COVID-19 outbreak","author":"Viale","year":"2020","journal-title":"Oncol."},{"key":"10.1016\/j.jbior.2020.100739_bib59","doi-asserted-by":"crossref","DOI":"10.1007\/s13555-020-00402-x","article-title":"Melanoma Screening Days during the coronavirus disease 2019 (COVID-19) pandemic: strategies to adopt","author":"Villani","year":"2020","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.jbior.2020.100739_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2020.05.026","article-title":"Effects of age and sex on recovery from COVID-19: analysis of 5769 Israeli patients","author":"Voinsky","year":"2020","journal-title":"J. Infect."},{"key":"10.1016\/j.jbior.2020.100739_bib61","doi-asserted-by":"crossref","DOI":"10.1530\/EJE-20-0269","article-title":"Endocrinology in the time of COVID-19: management of thyroid nodules and cancer","author":"Vrachimis","year":"2020","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.jbior.2020.100739_bib62","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2020.31.e68","article-title":"Recommendations on management of gynecological malignancies during the COVID-19 pandemic: perspectives from Chinese gynecological oncologists","author":"Wang","year":"2020","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.jbior.2020.100739_bib63","doi-asserted-by":"crossref","DOI":"10.1111\/codi.15112","article-title":"COVID-19: impact on colorectal surgery","author":"Wexner","year":"2020","journal-title":"Colorectal Dis."},{"key":"10.1016\/j.jbior.2020.100739_bib64","doi-asserted-by":"crossref","DOI":"10.1177\/1078155220924084","article-title":"Clinical course of COVID-19 infection in elderly patient with melanoma on nivolumab","author":"Yekeduz","year":"2020","journal-title":"J. Oncol. Pharm. Pract."},{"key":"10.1016\/j.jbior.2020.100739_bib65","doi-asserted-by":"crossref","DOI":"10.1177\/0194599820933185","article-title":"Care of patients with a laryngectomy during the COVID-19 pandemic","author":"Yeung","year":"2020","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"10.1016\/j.jbior.2020.100739_bib67","doi-asserted-by":"crossref","unstructured":"Zhou, Y., Hou, Y., Shen, J.,Huang, Y., Martin, W., Cheng, F. 2000. Network-based drug repurposing for novel coronavirus 2019-nCoV\/SARS-CoV-2. Cell Discov. 6:14. Published 2020 Mar 16. doi:10.1038\/s41421-020-0153.","DOI":"10.1038\/s41421-020-0153-3"}],"container-title":["Advances in Biological Regulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212492620300506?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212492620300506?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T12:56:50Z","timestamp":1778849810000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212492620300506"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":68,"alternative-id":["S2212492620300506"],"URL":"https:\/\/doi.org\/10.1016\/j.jbior.2020.100739","relation":{},"ISSN":["2212-4926"],"issn-type":[{"value":"2212-4926","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer therapy and treatments during COVID-19 era","name":"articletitle","label":"Article Title"},{"value":"Advances in Biological Regulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbior.2020.100739","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"100739"}}